HALOZYME THERAPEUTICS, INC. (HALO) Operating income 2016–2025
HALOZYME THERAPEUTICS, INC. (HALO) annual operating income history from SEC filings — each fiscal year as reported.
$469.0MFY2025 · since FY2016: -$83.2M → $469.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $469.0M | -15.0% |
| FY2024 | $551.5M | +63.4% |
| FY2023 | $337.6M | +26.2% |
| FY2022 | $267.5M | -3.0% |
| FY2021 | $275.9M | +91.3% |
| FY2020 | $144.3M | +313.4% |
| FY2019 | -$67.6M | +2.5% |
| FY2018 | -$69.3M | -185.6% |
| FY2017 | $81.0M | +197.3% |
| FY2016 | -$83.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice